Login


Notice: Passwords are now case-sensitive

Remember Me
Register a new account
Forgot your password?

Study: Drug Companies Paid $11.5 Million to Gabapentinoid Prescribers

By Elaine Goodman (medical/business Reporter)

Friday, July 12, 2019 | 585 | 0 | 87 min read

Drug company payments may be influencing doctors to prescribe brand name gabapentinoids — pain-killing drugs sometimes used as a substitute for opioids — rather than less expensive generics, according to a study published this week in JAMA Internal Medicine. The study, by Taeho Greg Rhee from the University of Connecticut, and colleagues from Yale University, looked at prescribing under the Medicare Part D program. But some say a similar connection between drug company payments and prescribing is possible in workers’ compensation. “It’s likely to ...

Purchase this story for only $7.99!Add to Cart


For access to all of our articles, check out our subscription options.

Comments

Related Articles